Morgan Stanley
PILL icon

Morgan Stanley’s Direxion Daily Pharmaceutical & Medical Bull 3X ETF PILL Stock Holding History

Morgan Stanley’s Portfolio PILL Stock Details PILL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38 Hold
2
– – ﹤0.01% 8168
2026
Q1 		$29 Hold
2
– – ﹤0.01% 8111
2025
Q4 		$28 Hold
2
– – ﹤0.01% 8020
2025
Q3 		$19 Sell
2
-135
-99% -$915 ﹤0.01% 8062
2025
Q2 		$713 Buy
137
+76
+125% +$394 ﹤0.01% 7370
2025
Q1 		$441 Buy
61
+60
+6,000% +$449 ﹤0.01% 7390
2024
Q4 		$12 Sell
1
-80
-99% -$687 ﹤0.01% 7904
2024
Q3 		$672 Buy
+81
New +$610 ﹤0.01% 7272
2024
Q2 		– Sell
-1
Closed -$11 – 7935
2024
Q1 		$11 Hold
1
– – ﹤0.01% 7760
2023
Q4 		$14 Buy
+1
New +$6 ﹤0.01% 7740

Other funds holding PILL

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FC
Financial Consulate Hunt Valley, Maryland $899M AUM 20.23% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Morgan Stanley's PILL Position: Q2 2026 in Review

Morgan Stanley held its Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) position steady in Q2 2026 at 2 shares worth $38. The position accounts for ﹤0.01% of the portfolio, ranked #8168.

Morgan Stanley first reported a position in PILL in Q4 2023 and has held it in 10 quarters since. The position peaked at $713 in Q2 2025. 7 funds tracked by Wall St. Rank hold PILL as of Q2 2026.

  • Morgan Stanley held 2 shares of Direxion Daily Pharmaceutical & Medical Bull 3X ETF worth $38 as of Q2 2026.
  • Morgan Stanley left its Direxion Daily Pharmaceutical & Medical Bull 3X ETF share count unchanged in Q2 2026.
  • Direxion Daily Pharmaceutical & Medical Bull 3X ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #8168 holding.
  • Morgan Stanley first reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in Q4 2023 and has held it in 10 quarters since.
  • Morgan Stanley's Direxion Daily Pharmaceutical & Medical Bull 3X ETF position peaked at $713 in Q2 2025.
  • 7 funds tracked by Wall St. Rank held Direxion Daily Pharmaceutical & Medical Bull 3X ETF as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.